3rd Quarter - Report

BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for NOVO NORDISK, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare reimbursement for Part D drugs; H.R. 2404 and S. 1509, Treat and Reduce Obesity Act. S.1131, Medicare Diabetes Prevention Act of 2015.

LobbyistCovered position, as disclosed
NICOLE CARELLI —
CAROLINE SELBY —
TIFFANI VIVIENNE WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2404 (114th), S. 1509 (114th), S. 1131 (114th)

Budget/Appropriations BUD

FY16 Labor-Education-HHS Appropriations bills, issues related to the National Diabetes Prevention Program.

LobbyistCovered position, as disclosed
TIFFANI VIVIENNE WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

H.R. 1192/S. 586, The National Diabetes Clinical Care Commission Act.

LobbyistCovered position, as disclosed
NICOLE CARELLI —
VERONICA POLLOCK New —
CAROLINE SELBY —
TIFFANI VIVIENNE WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 586 (114th), H.R. 1192 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.